Silversmith Partners I GP sells 3,592,357 LFST shares at $5.07; exit trims 20.1% of stake as stock trades 34.5% below 52-week high.
Silversmith Partners I GP sold 3,592,357 shares of LifeStance Health on 2025-08-18 at $5.07, reducing its stake by 20.1% to 14,324,197 shares. The sale occurred at a significant discount: the stock currently trades at $5.35, down 34.5% from its 52-week high of $8.17, though it has recovered 28.3% over the past 30 days. Notably, the insider's prior sell at this same ticker on 2024-05-24 was poorly timed, as the stock subsequently posted a 90-day return of 2.2%—meaning the insider sold before a gain, not a decline. LFST remains unprofitable (net income $-3.8M in the latest quarter), though the company shows strong revenue growth of 18.5% year-over-year on a base of $345.3M quarterly revenue. The partial divestiture in a depressed price environment, combined with the historical pattern of mistimed sells at this ticker, warrants attention to whether Silversmith's liquidity needs or confidence in the recovery may be driving the decision.